Marinomed Biotech AG (VIE:MARI)

Austria · Delayed Price · Currency is EUR

4.500

0.00 (0.00%)

Aug 27, 2026, 1:30 PM CET

Marinomed Biotech AG Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	7.96	7.96	4.79	9.4	11.74	11.63
Revenue Growth	66.08%	66.08%	-49.01%	-19.96%	1.00%	43.12%
Gross Profit	6.54	6.54	1.03	1.32	2.35	1.2
Operating Income	-0.26	-0.26	-6.98	-6.01	-5.28	-5.66
Net Income	18.02	18.02	-15.42	-6.37	-6.4	-5.89
Earnings Per Share	9.79	9.79	-8.67	-4.19	-4.30	-4.00
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Austria	0.54	0.54	0.34	0.54	0.99	0.6
Other European Countries	6.69	6.69	3.38	4.46	6.86	5.87
Non-European Countries	0.46	0.46	1.04	4.06	3.43	5.15
Total	7.69	7.69	4.75	9.06	11.28	11.63

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	0.95	0.95	1.71	2.56	8.18	5.8
Total Debt	11.56	11.56	29.28	21.58	22.63	15.8
Net Cash (Debt)	-10.61	-10.61	-27.57	-19.02	-14.45	-10
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-5.77	-5.77	-15.50	-12.53	-9.64	-6.77

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-1.1	-1.1	-2.4	-3.7	-5.2	-4.87
Capital Expenditures	-	-	-	-	-0.23	-0.92
Free Cash Flow	-1.1	-1.1	-2.4	-3.7	-5.43	-5.79
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	82.15%	82.15%	21.40%	14.07%	20.00%	10.32%
Operating Margin	-3.31%	-3.31%	-145.55%	-63.97%	-44.99%	-48.67%
Pretax Margin	227.69%	227.69%	-323.72%	-67.68%	-54.42%	-48.97%
Profit Margin	226.36%	226.36%	-321.66%	-67.72%	-54.48%	-50.67%
FCF Margin	-13.82%	-13.82%	-50.08%	-39.37%	-46.24%	-49.75%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	0.46	1.95	-	-	-	-
Forward PE	3.63	3.41	11.11	17.72	17.72	15.78
PS Ratio	1.13	4.42	5.57	4.72	7.23	11.20